| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6183778 | CHIESI | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
Sep, 2013
(10 years ago) | |
Zyflo Cr is owned by Chiesi.
Zyflo Cr contains Zileuton.
Zyflo Cr has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Zyflo Cr are:
- US6183778
Zyflo Cr was authorised for market use on 30 May, 2007.
Zyflo Cr is available in tablet, extended release;oral dosage forms.
The generics of Zyflo Cr are possible to be released after 21 September, 2013.
Drugs and Companies using ZILEUTON ingredient
Market Authorisation Date: 30 May, 2007
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
ZYFLO CR family patents
